Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - HUMAN GENOME SCIENCES INC | c97177exv99w1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 2, 2010
HUMAN GENOME SCIENCES, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 001-14169 | 22-3178468 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
| 14200 Shady Grove Road, Rockville, Maryland |
20850-7464 |
|
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (301) 309-8504
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Section 2 — Financial Information
Item 2.02. Results of Operations and Financial Condition.
On March 2, 2010, Human Genome Sciences, Inc. (the “Company”) issued a press release
announcing its financial results for the quarter and full year ended December 31, 2009. A copy of
the release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this section of this Report on Form 8-K and Exhibit 99.1 attached hereto
shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934,
nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933,
except as shall be expressly set forth by specific reference in such filing.
Section 9 — Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
| 99.1 | Press Release dated March 2, 2010 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| HUMAN GENOME SCIENCES, INC. |
||||
| By: | /s/ James H. Davis, Ph.D. | |||
| Name: | James H. Davis, Ph.D. | |||
| Title: | Executive Vice President, General Counsel and Secretary |
|||
Date: March 2, 2010
INDEX TO EXHIBITS
| Exhibit No. | Description | |
| Exhibit 99.1 | Press Release dated March 2, 2010. |